|Day's Range||81.2200 - 81.5600|
|52 Week Range||66.9300 - 83.5800|
|PE Ratio (TTM)||30.58|
|Dividend & Yield||2.72 (3.35%)|
|1y Target Est||N/A|
A costly learning exercise.
In 2016, Amgen’s (AMGN) Neulasta generated revenues close to $4.6 billion, which was a slight drop from its 2015 net sales of ~$4.7 billion.
We issued an updated research report on Alnylam Pharmaceuticals, Inc. (ALNY) on May 23, 2017.